Cryoneurolysis for Spasticity: Long-Lasting Relief, Candidate Criteria, and What the Evidence Shows
NeuroRehab Team
Tuesday, December 30th, 2025
Spasticity affects about 2.58 million adults in the United States. Nearly 1.07 million of these people face troublesome symptoms that disrupt their quality of life. Patients struggling with this condition can now turn to cryoneurolysis treatment. This option works better than traditional approaches and provides longer-lasting relief without the drawbacks of conventional therapies.
Everything You Need To Know About Cryoneurolysis for Spasticity: Who, What, When, & How.
NeuroRehab Team
Thursday, December 4th, 2025
Neurological conditions bring spasticity to many patients. The numbers are striking – 80% of spinal cord injury patients, 39.5% of stroke patients with paresis, and 84% of those with multiple sclerosis experience this condition. Traditional treatments like oral anti-spasmodics and botulinum toxin injections help patients find relief, yet they have their limitations. Botulinum toxin stands as a first-line treatment for focal spasticity, but its effects last only 3-4 months before requiring another treatment.
